BR112014022694B1 - método para a preparação de uma composição aquosa terapêutica, extrato de ervas e composição farmacêutica contendo o referido extrato - Google Patents

método para a preparação de uma composição aquosa terapêutica, extrato de ervas e composição farmacêutica contendo o referido extrato Download PDF

Info

Publication number
BR112014022694B1
BR112014022694B1 BR112014022694-6A BR112014022694A BR112014022694B1 BR 112014022694 B1 BR112014022694 B1 BR 112014022694B1 BR 112014022694 A BR112014022694 A BR 112014022694A BR 112014022694 B1 BR112014022694 B1 BR 112014022694B1
Authority
BR
Brazil
Prior art keywords
extract
fact
pharmaceutical composition
alcohol
disease
Prior art date
Application number
BR112014022694-6A
Other languages
English (en)
Portuguese (pt)
Other versions
BR112014022694A2 (en
Inventor
Amy Debra Rosenbluh
Jay Gabriel Nussbaum
Avner Rotman
Original Assignee
Izun Pharmaceuticals Corp.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Izun Pharmaceuticals Corp. filed Critical Izun Pharmaceuticals Corp.
Publication of BR112014022694A2 publication Critical patent/BR112014022694A2/en
Publication of BR112014022694B1 publication Critical patent/BR112014022694B1/pt

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/35—Caprifoliaceae (Honeysuckle family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D11/00—Solvent extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30—Extraction of the material
    • A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30—Extraction of the material
    • A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/50—Methods involving additional extraction steps
    • A61K2236/53—Liquid-solid separation, e.g. centrifugation, sedimentation or crystallization

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Dermatology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
BR112014022694-6A 2012-03-14 2013-03-13 método para a preparação de uma composição aquosa terapêutica, extrato de ervas e composição farmacêutica contendo o referido extrato BR112014022694B1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261610480P 2012-03-14 2012-03-14
US61/610,480 2012-03-14
PCT/IB2013/051970 WO2013136270A1 (en) 2012-03-14 2013-03-13 Novel methods and compositions for treatment of disease

Publications (2)

Publication Number Publication Date
BR112014022694A2 BR112014022694A2 (en) 2018-02-27
BR112014022694B1 true BR112014022694B1 (pt) 2021-03-09

Family

ID=48190560

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112014022694-6A BR112014022694B1 (pt) 2012-03-14 2013-03-13 método para a preparação de uma composição aquosa terapêutica, extrato de ervas e composição farmacêutica contendo o referido extrato

Country Status (13)

Country Link
US (2) US20150064291A1 (https=)
EP (1) EP2825185B1 (https=)
JP (1) JP6410355B2 (https=)
KR (1) KR102168118B1 (https=)
CN (1) CN104394875B (https=)
AU (1) AU2013233943B2 (https=)
BR (1) BR112014022694B1 (https=)
CA (1) CA2867260C (https=)
ES (1) ES3014157T3 (https=)
IL (1) IL234606B (https=)
IN (1) IN2014DN08440A (https=)
RU (1) RU2683774C2 (https=)
WO (1) WO2013136270A1 (https=)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3057601A4 (en) 2013-10-14 2017-06-21 Izun Pharmaceuticals Corp. Methods for treatment of m-tor inhibitor-associated stomatitis
KR101649450B1 (ko) * 2015-08-19 2016-08-18 이상철 피부 상처 치료조성물
IL258309B2 (en) * 2015-09-24 2023-03-01 Caris Science Inc Method, device and product of computer software for analyzing biological data
KR101751486B1 (ko) * 2016-03-02 2017-06-28 광주과학기술원 BKCa 채널 활성화용 조성물
JP7121944B2 (ja) * 2018-05-07 2022-08-19 国立大学法人信州大学 ナノ繊維及びその製造方法
IL262744B (en) * 2018-11-04 2020-03-31 Izun Pharmaceuticals Corp Hydrogel compositions comprising plant extracts
RU2716501C1 (ru) * 2019-03-11 2020-03-12 Тамара Владимировна Пономаренко Композиция для профилактики и лечения воспалительных заболеваний полости рта
EP4236978A4 (en) 2020-10-28 2024-09-11 Izun Pharmaceuticals Corp. Treatment of oral mucositis
KR102613837B1 (ko) * 2021-11-25 2023-12-15 주식회사 젠트리바이오 천연물질 추출물의 혼합물을 주성분으로 하는 항산화 및 항염증 효능을 갖는 조성물 및 그 제조방법

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU931188A1 (ru) * 1980-04-22 1982-05-30 Запорожский государственный медицинский институт Способ получени фенольных соединений,обладающих противовоспалительным действием
JP2001048798A (ja) * 1999-08-06 2001-02-20 Sakamoto Yakuhin Kogyo Co Ltd 抗菌剤
IL143318A0 (en) * 2001-05-23 2002-04-21 Herbal Synthesis Corp Herbal compositions for the treatment of mucosal lesions
CN1137115C (zh) * 2001-11-24 2004-02-04 广东梅州市梅雁螺旋藻高科技研究所 从柚皮中提取黄酮的方法
ITMI20021691A1 (it) * 2002-07-30 2004-01-30 Indena Spa Estratti di echinacea angustifolia
JP2005179252A (ja) * 2003-12-19 2005-07-07 Taiyo Kagaku Co Ltd 血栓形成抑制剤
EP1604647B1 (en) * 2004-05-12 2008-05-07 Chisso Corporation Cosmetic composition containing polyorganosiloxane-containing epsilon-polylysine polymer, and polyhydric alcohol, and production thereof
ES2299082T3 (es) * 2004-09-01 2008-05-16 Labtec Gesellschaft Fur Technologische Forschung Und Entwicklung Mbh Parche para cavidades.
KR20090026804A (ko) * 2006-06-20 2009-03-13 이준 파마슈티컬스 코포레이션 항염증 용해 가능한 필름
KR101474809B1 (ko) * 2006-07-20 2014-12-19 이준 파마슈티컬스 코포레이션 필름 전달 린스
WO2009078022A2 (en) * 2007-12-17 2009-06-25 Izun Pharmaceuticals Corporation Synergistic combinations of growth factors with herbal compositions for the enhancement of tissue repair
JP5707655B2 (ja) * 2008-07-22 2015-04-30 イズン ファーマシューティカルズ， インコーポレイテッド 局所的抗炎症配合剤
US8853774B2 (en) 2012-11-30 2014-10-07 Infineon Technologies Ag Semiconductor device including trenches and method of manufacturing a semiconductor device
KR102725403B1 (ko) 2018-11-16 2024-11-04 에스이에스 홀딩스 피티이. 엘티디. 리튬 이온 및 리튬 금속 배터리 내의 애노드에 대해 안정한 유기 용매를 사용하여 리튬 비스(플루오로설포닐)이미드 (LiFSI)로부터 반응성 용매를 제거하는 방법

Also Published As

Publication number Publication date
US20210128661A1 (en) 2021-05-06
BR112014022694A2 (en) 2018-02-27
IL234606B (en) 2021-04-29
US20150064291A1 (en) 2015-03-05
CN104394875A (zh) 2015-03-04
ES3014157T3 (en) 2025-04-21
JP2015514057A (ja) 2015-05-18
WO2013136270A1 (en) 2013-09-19
AU2013233943B2 (en) 2017-10-19
US12059445B2 (en) 2024-08-13
EP2825185A1 (en) 2015-01-21
IL234606A0 (en) 2014-11-30
JP6410355B2 (ja) 2018-10-24
AU2013233943A1 (en) 2014-09-25
RU2014136776A (ru) 2016-05-10
EP2825185C0 (en) 2025-01-08
CN104394875B (zh) 2018-12-04
KR20140138894A (ko) 2014-12-04
CA2867260C (en) 2021-10-05
CA2867260A1 (en) 2013-09-19
RU2683774C2 (ru) 2019-04-02
EP2825185B1 (en) 2025-01-08
IN2014DN08440A (https=) 2015-05-08
KR102168118B1 (ko) 2020-10-21

Similar Documents

Publication Publication Date Title
US12059445B2 (en) Methods for preparing anti-inflammatory herbal extracts comprising Sambucus nigra, Echinacea purpurea and Centella asiatica
ES2295482T3 (es) Extracto de plantas chinas.
ES2546402T3 (es) Composiciones a base de hierbas y métodos para tratar trastornos hepáticos
PT1395271E (pt) Composições à base de plantas para o tratamento de lesões de mucosas
BRPI0808065B1 (pt) Novas composições cosméticas e/ou farmacêuticas e suas aplicações
EP3086799A1 (en) Composition for use in the treatment of persistent cough
ES2661373T3 (es) Formulaciones a base de plantas
US20150273009A1 (en) New formulations comprising plant extracts
KR101225114B1 (ko) 봉독을 유효성분으로 함유하는 피부 미백 및 피부질환 예방 및 치료용 조성물
JP2003081800A (ja) 抗歯周病剤
ES2674874T3 (es) Composición antiinflamatoria
ES2394316T3 (es) Composiciones farmac�uticas de Carapa Guianensis.
RS57697B1 (sr) Kombinacija lipidtransferproteina i biljnih materija koje sadrže derivate fenola sa lokal-mukozalnim dejstvom
KR101059282B1 (ko) 금은화추출물을 유효성분으로 함유하는 약물 중독 및 금단증상의 예방 및 치료용 조성물
Ferdous et al. Studies on the anti-inflammatory and analgesic efficacy of Scindapsus officinalis (roxb.) schott in laboratory animals
RU2371194C2 (ru) Растительный сбор "анастасия"
WO2011120118A1 (pt) Processo de obtenção de micropartículas matriciais de copaífera langsdorffii (partes aéreas) e isolamento dos princípios ativos; micropartículas e compostos assim obtidos, com atividade antilitiásica (cálculo renal), analgésica, anti-espasmódica, anti-inflamatória, diurética e anti-séptica, suas formulações, produtos e usos.
US20160235798A1 (en) Methods for treatment of m-tor inhibitor-associated stomatitis
PAW EVALUATION OF ANTI-INFLAMMATORY ACTIVITY OF ALKALOID AND NON-ALKALOID LEAF EXTRACTS OF CALLISTEMON VIMINALIS BY CARRAGEENAN INDUCED PAW EDEMA IN AN-ANIMAL EXPERIMENTAL MODEL
BR102018000033A2 (pt) Fitoterápico antimicrobiano obtido a partir do extrato das folhas de syzygium malaccense l. (jambo vermelho)
KR20110034876A (ko) 초용담 추출물을 유효성분으로 함유하는 약물 중독 및 금단증상의 예방 및 치료용 조성물
BR102016004295A2 (pt) Composição farmacêutica de medicamento à base de própolis
BRPI1107326A2 (pt) formulação à base de julocroton triqueter (lam.) didr.var.triqueter de uso tópico para o tratamento de ulceras leishmanióticas
RO129524A2 (ro) Produs destinat eliminării psoriazisului

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.

B07B Technical examination (opinion): publication cancelled [chapter 7.2 patent gazette]

Free format text: ANULADA A PUBLICACAO CODIGO 7.4 NA RPI NO 2544 DE 08/10/2019 POR TER SIDO INDEVIDA.

B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 13/03/2013, OBSERVADAS AS CONDICOES LEGAIS.